FDA Inspection 776935 — Sheffield Pharmaceuticals, LLC

Sheffield Pharmaceuticals, LLC — FEI 1210513

The FDA completed an inspection of Sheffield Pharmaceuticals, LLC on Apr 13, 2012 in New London, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 13, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New London, CT (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
145021 CFR 211.113(a)Procedures for non-sterile drug products
435221 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
438721 CFR 211.198(a)Reporting of adverse drug experience to FDA
439021 CFR 211.180(c)Photocopying of records not allowed

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.